Nick Mamalis is an Ophthalmology physician affiliated with Intermountain Healthcare. OpenAlex indexes 434 publications with 11,847 citations (h-index 57). By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Moran Eye Ctr
65 Mario Capecchi Dr
Salt Lake City, UT 841320001
Telephone
801-581-2352Provider last certified this registry record 20 Nov 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year20255 payments
- Alcon Vision LLCProgram year20251 payment
- Alcon Research LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
58.2%Prostaglandin Analog39.7%Latanoprost100%Part D≥63 patientsCorticosteroid10.4%Prednisolone Acetate55%Fluorometholone45%Part D<11 patients+ 2 more classes in this area
Cancer & immunology
22.2%Calcineurin inhibitor22.2%Restasis90%Cyclosporine10%Part D<11 patientsCardiovascular
8.3%Beta blocker8.3%Timolol Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Standard for reporting refractive outcomes of intraocular lens–based refractive surgery
Journal of Cataract & Refractive Surgery
2017 - Cataract surgery and nonsteroidal antiinflammatory drugs
Journal of Cataract & Refractive Surgery
2016 - Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2014 ASCRS member survey
Journal of Cataract & Refractive Surgery
2015 - Multifocal intraocular lenses: Relative indications and contraindications for implantation
Journal of Cataract & Refractive Surgery
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Fabiana Ostronoff, MD
Intermountain Healthcare
Brian Whisenant, MD
Intermountain Healthcare
William Sause, MD
Intermountain Healthcare
Rajendu Srivastava, MD
Intermountain Healthcare
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”